Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.36 |
| ▸ | GAPDH | P04406 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 2/20 | 0.32 |
| ▸ | PPARG | P37231 | 2/20 | 0.31 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31197042 | 1.00 | TRPA1 (0.36) | TRPA1DDAH1GAPDHMAPTGPR84 | |
| SCHEMBL31197055 | 1.00 | TRPA1 (0.36) | TRPA1DDAH1GAPDHMAPTGPR84 | |
| SCHEMBL21551894 | 1.00 | TRPA1 (0.36) | TRPA1DDAH1GAPDHMAPTGPR84 | |
| SCHEMBL5691389 | 0.90 | — | — | |
| SCHEMBL5691385 | 0.90 | — | — | |
| SCHEMBL23528830 | 0.79 | CA12 (0.36) | TRPA1DDAH1GAPDHMAPTLMNA | |
| SCHEMBL21551873 | 0.79 | MAPT (0.39) | TRPA1DDAH1GAPDHMAPTPPARG | |
| SCHEMBL21552047 | 0.79 | TRPA1 (0.59) | TRPA1DDAH1GAPDHMAPTGPR84 | |
| SCHEMBL21551874 | 0.79 | MAPT (0.39) | TRPA1DDAH1GAPDHMAPTPPARG | |
| SCHEMBL14243849 | 0.79 | TRPA1 (0.59) | TRPA1DDAH1GAPDHMAPTGPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062720-A1 | Multifunctional Fatty Acid Derivatives And Biosynthesis Thereof | AGAIN BIO APS (DK) | 2026-03-05 | — | — | US | disclosed |
| US-20260009059-A1 | Production Of Non-Native Monounsaturated Fatty Acids In Bacteria | AGAIN BIO APS (DK) | 2026-01-08 | — | — | US | disclosed |
| US-12221644-B2 | Production of non-native monounsaturated fatty acids in bacteria | GENOMATICA, INC. (US) | 2025-02-11 | — | — | US | disclosed |
| US-20240309405-A1 | MULTIFUNCTIONAL FATTY ACID DERIVATIVES AND BIOSYNTHESIS THEREOF | OXFORD FINANCE LLC | 2024-09-19 | — | — | US | disclosed |
| EP-3844269-A1 | PRODUCTION OF NON-NATIVE MONOUNSATURATED FATTY ACIDS IN BACTERIA | Genomatica, Inc. (US) | 2021-07-07 | — | — | EP | disclosed |
| US-20210189439-A1 | Multifunctional Fatty Acid Derivatives And Biosynthesis Thereof | GENOMATICA, INC. (US) | 2021-06-24 | — | — | US | disclosed |
| US-20210189373-A1 | Production Of Non-Native Monounsaturated Fatty Acids In Bacteria | AGAIN BIO APS (DK) | 2021-06-24 | — | — | US | disclosed |
| EP-3810778-A1 | MULTIFUNCTIONAL FATTY ACID DERIVATIVES AND BIOSYNTHESIS THEREOF | Genomatica, Inc. (US) | 2021-04-28 | — | — | EP | disclosed |
| WO-2020047088-A1 | PRODUCTION OF NON-NATIVE MONOUNSATURATED FATTY ACIDS IN BACTERIA | GENOMATICA, INC. (US) | 2020-03-05 | — | — | WO | disclosed |
| WO-2019217226-A1 | MULTIFUNCTIONAL FATTY ACID DERIVATIVES AND BIOSYNTHESIS THEREOF | REG Life Sciences, LLC (US) | 2019-11-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062720-A1 | Multifunctional Fatty Acid Derivatives And Biosynthesis Thereof | FASN, FFAR1, FFAR3 | TRPA1 489/4885DDAH1 399/4885GAPDH 711/4885 |
| US-20260009059-A1 | Production Of Non-Native Monounsaturated Fatty Acids In Bacteria | FLAD1, FADS2, COASY | TRPA1 3805/4885DDAH1 978/4885GAPDH 163/4885 |
| US-20240309405-A1 | MULTIFUNCTIONAL FATTY ACID DERIVATIVES AND BIOSYNTHESIS THEREOF | DGAT2, DGAT1, FASN | TRPA1 568/4885DDAH1 653/4885GAPDH 801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.